Data / Drug companies / Harman Finochem Limited
Harman Finochem Limited: 60 products in the FDA NDC directory, labeler code 66064
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Harman Finochem Limited (labeler code 66064) lists 60 products in the FDA National Drug Code Directory. By type: 60 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on January 27, 2026.
The request: Watch Harman Finochem Limited (FDA labeler code 66064): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66064
- Products in commercial distribution
- 60
- Packages
- 60
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 5
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- January 2, 2002
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 60 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 60 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 59 | 98.3% |
| Liquid | 1 | 1.7% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Nicotine polacrilex | 66064-1053 | Powder | Bulk ingredients | January 27, 2026 |
| Glycopyrrolate | 66064-3100 | Powder | Bulk ingredients | November 1, 2025 |
| Glycopyrrolate | 66064-3100 | Powder | Bulk ingredients | November 1, 2025 |
| Potassium acetate | 66064-1037 | Powder | Bulk ingredients | August 13, 2025 |
| Glycopyrrolate | 66064-3100 | Powder | Bulk ingredients | January 1, 2025 |
| Epinephrine | 66064-1052 | Powder | Bulk ingredients | April 1, 2024 |
| Nicotine polacrilex | 66064-1053 | Powder | Bulk ingredients | January 4, 2024 |
| Epinephrine bitartrate | 66064-1049 | Powder | Bulk ingredients | April 1, 2023 |
| Phenylbutazone | 66064-1050 | Powder | Bulk ingredients | November 1, 2022 |
| Nicotine | 66064-1038 | Liquid | Bulk ingredients | July 15, 2022 |
| R-oxybutynin hydrochloride | 66064-1045 | Powder | Bulk ingredients | December 1, 2021 |
| Potassium acetate | 66064-1037 | Powder | Bulk ingredients | July 1, 2021 |
| Methylcobalamin | 66064-1036 | Powder | Bulk ingredients | April 1, 2020 |
| Fospropofol disodium | 66064-1034 | Powder | Bulk ingredients | February 1, 2020 |
| Glycopyrrolate tosylate | 66064-1032 | Powder | Bulk ingredients | March 1, 2019 |
| Valsartan disodium | 66064-1033 | Powder | Bulk ingredients | December 17, 2018 |
| Bupivacaine hydrochloride | 66064-1031 | Powder | Bulk ingredients | January 1, 2018 |
| Calcium gluconate monohydrate | 66064-1027 | Powder | Bulk ingredients | April 1, 2017 |
| Norepinephrine bitartrate | 66064-1025 | Powder | Bulk ingredients | February 1, 2017 |
| Dapagliflozin | 66064-1029 | Powder | Bulk ingredients | January 1, 2017 |
| Succinylcholine chloride | 66064-1028 | Powder | Bulk ingredients | January 1, 2017 |
| Sacubitril/valsartan | 66064-1026 | Powder | Bulk ingredients | January 1, 2017 |
| Efinaconazole | 66064-1024 | Powder | Bulk ingredients | January 1, 2017 |
| Benztropine mesylate | 66064-1023 | Powder | Bulk ingredients | January 1, 2017 |
| Isoproterenol hydrochloride | 66064-1021 | Powder | Bulk ingredients | January 12, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.